Svetec, D <br/><br/>
Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer.  [electronic resource] 

 -  The Journal of urology  May 1998 
 - 1606-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-5347 
<br/><br/><label>Standard No.: </label>10.1097/00005392-199805000-00052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood<br/>Aged<br/>Biopsy<br/>False Negative Reactions<br/>Humans<br/>Male<br/>Middle Aged<br/>Predictive Value of Tests<br/>Prostate--pathology<br/>Prostate-Specific Antigen--analysis<br/>Prostatectomy<br/>Prostatic Neoplasms--blood<br/>ROC Curve<br/>Treatment Outcome